Navid Nedjatian

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Massachusetts General Hospital(Current)

Novo Nordisk (Switzerland)

Novo Nordisk (Denmark)

Karolinska University Hospital

Allegheny General Hospital

Navid Nedjatian is an author at Massachusetts General Hospital specializing in medicine, growth hormone replacement therapy, and comprehensive geriatric assessment.

ORCID

Publications per year

2021–2023

Publications

Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency

Yutaka Takahashi, Beverly M. K. Biller, Hidenori Fukuoka et al. · Pituitary · 2022 · 15 citations · Full text

Medicine, Endocrinology, Diabetology +16

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program

Beverly M. K. Biller, Charlotte Höybye, Paul Carroll et al. · Pituitary · 2021 · 13 citations · Full text

Medicine, Endocrinology, Obstetrics +13

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

Beverly M. K. Biller, Charlotte Höybye, Jean-Marc Ferran et al. · Journal of the Endocrine Society · 2023 · 11 citations · Full text

Medicine, Geriatric Medicine, Internal Medicine +12

1–3 of 3